Molecular basis of triiodothyronine myogenic influence;Mecanismes moleculaires impliques dans l'activite myogenique de la triiodothyronine (T3)

Medecine/Sciences

Volumn 12, Issue 10, 1996, Pages 1065-1076

  Marchal, Sophie ^a   Cassar Malek, Isabelle ^a   Rodier, Anne ^a   Wrutniak, Chantal ^a   Cabello, Gérard ^a  

^a CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYCLIC AMP; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; LIOTHYRONINE; MYOSIN; RETINOID X RECEPTOR; THYROID HORMONE; TRANSCRIPTION FACTOR AP 1;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL CYCLE; CELL DIFFERENTIATION; CULTURE MEDIUM; FOWL; GENE REPRESSION; GENETIC TRANSCRIPTION; HEART MUSCLE; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE MITOCHONDRION; MYOBLAST; NONHUMAN; PROTEIN EXPRESSION; PROTEIN TRANSPORT; SKELETAL MUSCLE; TRANSCRIPTION INITIATION;

ANIMALIA; AVES; GALLIFORMES; MURINAE;

EID: 0029801426     PISSN: 07670974     EISSN: None     Source Type: Journal    
DOI: 10.4267/10608/622     Document Type: Article

References (73)

1. Scow RO. Effect of growth hormone on muscle and skin collagen in neonatal thyroidectomized rats. Endocrinology 1951 ; 49 : 641-6.
2. Sugie H, Verity MA. Postnatal histochemical fiber type differentiation in normal and hypothyroid rat soleus muscle. Muscle Nerve 1985; 8: 654-60.
3. King DM. Thyroidal influence on nuclear accumulation and DNA replication in skeletal muscles of young chickens. J Expert Zool 1987; suppl 1: 291-8.
4. Legrand J. Thyroid hormone effects on growth and development. In: Hennemann I, ed. Thyroid hormone metabolism. New York: Marcel Dekker Inc., 1986: 503-34.
5. Cabello G, Wrutniak C. Fonction thyroïdienne foetale et néonatale chez le ruminant; importance physiologique. In: Jarrige R, ed. Physiologie et pathologie néonatale chez les animaux de ferme. Paris: Inra, 1984 : 255-74.
6. Yaoita Y, Brown DD. A correlation of thyroid hormone receptor gene expression with amphibian metamorphosis. Genes Dev 1990; 4: 1917-24.
7. Wang Z, Brown DD. Thyroid hormone-induced gene expression program for amphibian tail resorption. J Biol Chem 1993 ; 22: 16270-8.
8. Whalen RG, Sell SM, Butler-Browne GS, Schwartz K, Bouveret P, Pinset-Haestrom I. Three myosin heavy chain isozymes appear sequentially in rat muscle development. Nature 1981 ; 292: 805-9.
9. Butler-Browne GS, Herlicoviez D, Whalen RG. Effects of hypothyroidism on myosin isozymes transition in developing rat muscle. FEBS Lett 1984; 166: 71-5.
10. Gustafson TA, Markham BE, Bahl JJ, Morkin E. Thyroid hormone regulates expression of a transfected α-myosin heavy chain fusion gene in fetal heart cells. Proc Natl Acad Sci USA 1987; 84: 3122-6.
11. Green NK, Franklin JA, Ahlquist JAO, Gammage MD, Sheppard MC. Differential regulation by thyroid hormones of myosin Heavy Chain α and β mRNAs in the rat ventricular myocardium. J Endocrinol 1989; 122: 193-200.
12. Izumo S, Nadal-Ginard B, Mahdavi V. All members of the MHC multigene family respond to thyroid hormone in highly tissue-specific manner. Science 1986; 231 : 597-600.
13. Ianuzzo D, Patel P, Chen V, O'Brien P, Williams C. Thyroidal trophic influence on skeletal muscle myosin. Nature 1977; 270: 74-6.
14. Hoffman RK, Lazar MA, Rubinstein MA, Kelly AM. Differential expression of α1, α2 and β1 thyroid hormone receptor genes in developing rat skeletal muscle. J Cell Biochem 1994; 18D (suppl) : 517.
15. Brown GC. Control of respiration and ATP synthesis in mammalian mitochondria and cells. Biochem J 1992; 284: 1-13.
16. Wrutniak C, Cabello G. La voie d'action mitochondriale directe de la T3. Mythe ou réalité ? médecine/sciences 1996; 12: 475-84.
17. Sterling K, Brenner MA, Sakurada T. Rapid effect of triiodothyronin on the mitochondrial pathway in rat liver in vivo. Science 1980; 210: 340-3.
18. Wrutniak C, Cassar-Malek I, Marchal S, Rascle A, Heusser S, Keller JM, Fléchon J, Dauça M, Samarut J, Ghysdael J, Cabello G. A 43-kDa Protein related to c-erbA α1 is located in the mitochondrial matrix of rat liver. J Biol Chem 1995; 270: 16347-54.
19. Spizz H, Romar D, Strauss A, Olson N. Serum and fibroblast growth factor inhibit myogenic differentiation through a mechanism dependent of protein synthesis and independent of cell proliferation. J Biol Chem 1986; 261: 9483-8.
20. Bengal E, Ransone L, Scharfmann R, Dwarki VJ, Tapscott S, Weintraub H, Verma IM. Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell 1992; 68: 507-19.
21. Lassar AB, Thayer MJ, Overell RW, Weintraub H. Transformation by activated ras or Fos prevents myogenesis by inhibiting expression of MyoD. Cell 1989; 58: 659-67.
22. Rudniki MA, Schnegelsberg PNJ, Stead RH, Braun T, Arnold HH, Jaenisch R. MyoD or Myf-5 is required for the formation of skeletal muscle. Cell 1993; 75: 1351-9.
23. Hasty P, Bradley A, Morris JH, Edmonson DG, Venuti JM, Olson EN, Klein WH. Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene. Nature 1993; 364: 501-6.
24. Nabeshima Y, Hanaoka K, Hayasaka M, Esumi E, Shawoei L, Nonaka L, Nonaka I, Nabeshima YI. Myogenin gene disruption results in perinatal lethality because of severe muscle defect. Nature 1993; 364: 532-5.
25. Braun T, Arnold HH. Inactivation of Myf-6 and Myf-5 genes in mice leads to alterations in skeletal muscle development. EMBO J 1995; 14: 1176-86.
26. Zhang W, Behinger RR, Olson EN. Inactivation of myogenic bHLH gene MRF4 results in up-regulation of myogenin and rib anormalities. Genes Dev 1995; 9: 1388-99.
27. Alonso S. Des facteurs de régulation spécifiques de la myogenèse, médecine/ sciences 1990; 6: 635-44.
28. Murre C, McCaw P, Vaessin H, Caudy M, Cabrera C, Buskin J, Hauschka S, Lassar A, Weintraub H, Baltimore D. Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell 1989; 58: 537-44.
29. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H. The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 1990; 61: 49-59.
30. Martin JF, Schwarz JJ, Olson EN. Myocyte Enhancer Factor (MEF 2C) : a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci USA 1993; 90: 5282-6.
31. Edmonson DG, Cheng TC, Cserjesi P, Chahraborty T, Olson EN. Analysis of the myogenin promotor reveals an undirect pathway for positive autoregulation mediated by the muscle specific-enhancer factor MEF-2. Mol Cell Biol 1992; 12: 3665-77.
32. Olson EN. Interplay between proliferation and differentiation within the myogenic lineage. Dev Biol 1992; 154: 261-72.
33. Gu W, Schneider JW, Condorelli G, Kaushal S, Mahdavi V, Nadal-Ginard B. Interactions of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 1993; 72: 309-24.
34. Skapek SX, Rhee J, Spicer DB, Lassar AB. Inhibition of myogenic differentiation in proliferating myoblasts by cyclin D1-dependent kinase. Science 1995; 267: 1022-7.
35. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee T, Hannon GJ, Beach D, Lassar AB. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018-21.
36. Li L, Chambard JC, Karin M, Olson E.N. Fos and Jun repress transcriptional activation by myogenin and MyoD : the amino terminus of Jun can mediate repression. Genes Dev 1992; 6: 676-89.
37. Park K, Chung M, Kim SJ. Inhibition of myogenesis by okadaic acid, an inhibitor of protein phosphatases 1 and 2A, correlates with the induction of AP-1. J Biol Chem 1992; 276: 10810-5.
38. Marchal S, Cassar-Malek I, Pons F, Wrutniak C, Cabello G. Triiodothyronine influences quail myoblast proliferation and differentiation. Biol Cell 1993; 78: 191-7.
39. Marchal S, Cassar-Malek I, Magaud JP, Rouault JP, Wrutniak C, Cabello G. Stimulation or avian myoblast differentiation by triiodothyronine : possible involvement of the cAMP pathway. Exp Cell Res 1995; 22: 1-10.
40. Carnac G, Albagli-Curiel O, Vandromme M, Pinset C, Montarras D, Laudet V, Bonnieu A. 3, 5, 3′-triiodothyronine positively regulates both MyoD1 gene transcription and terminal differentiation in C2 myoblasts. Mol Endocrinol 1992; 6: 1185-94.
41. Albagli-Curiel O, Carnac G, Vandromme M, Vincent S, Crépieux P, Bonnieu A. Serum-induced inhibition of myogenesis is differentially relieved by retinoic acid and triiodothyronine in C2 murine muscle cells. Differentiation 1993; 52: 201-10.
42. Tapscott SJ, Lassar BA, Davis LR, Weintiaub H. 5-Bromo-2′-deoxyuridine blocks myogenesis by extinguishing expression of MyoD1. Science 1989; 245: 532-6.
43. Lezoualc'h F, Seugnet I, Monnier AL, Ghysdael J, Behr JP, Demeneix BA. Inhibition of neurogenic precursor proliferation by antisense α thyroid hormone receptor oligonucleotides. J Biol Chem 1995; 270: 12100-8.
44. Prati M, Calvo R, Morreale de Escobar G. L-thyroxine and 3, 5, 3′-triiodothyronine concentrations in the chicken eggs and in the embryo before and after the onset of thyroid function. Endocrinology 1992; 130: 2651-9.
45. Forrest D, Sjoberg M, Vennstrom B. Contrasting developmental and tissue-specific expression of α and β thyroid hormone receptor genes. EMBO J 1990; 9: 1519-28.
46. Cassar-Malek I, Marchai S, Altabef M, Wrutniak C, Samarut J, Cabello G. V-erb A stimulates quail myoblast differentiation in a T3-independent, cell-specific manner. Oncogene 1994; 9: 2197-206.
47. Cassar-Malek I. Influence de la forme oncogénique v-erb A du récepteur nucléaire de la T3 c-erbA α1 sur la différenciation des myoblastes de caille. Mécanismes d'action. Thèse d'Université, Montpellier II, 1994: 155 p.
48. Cassar-Malek I, Marchal S, Rochard P, Casas F, Wrutniak C, Samarut J, Cabello G. Induction of c-erbA/AP-1 interactions and c-erbA transcriptional activity in myoblasts by RXR. Consequences for muscle differentiation. J Biol Chem 1996; 271: 11392-9.
49. Desbois C, Aubert D, Legrand C, Pain B, Samarut J. A novel mechanism of action for v-erb A: abrogation of the inactivation of the transcription factor AP-1 by retinoic and thyroid hormone receptors. Cell 1991 ; 67: 731-40.
50. Zhang XK, Wills KN, Husmann N, Hermann T, Pfahl M. Novel pathway for thyroid hormone receptor action through interaction with jun and fos oncogene activities. Mol Cell Biol 1991 ; 11 : 6016-25.
51. Downes M, Griggs R, Atkins A, Olson EN, Muscat GEO. Identification of a thyroid hormone responsive element in the mouse myogenin gene: characterization of the thyroid hormone and retinoid X receptor heterodimeric binding site. Cell Growth Differ 1993; 4: 901-9.
52. Muscat GEO, Mynett-Johnson L, Dowhan D, Downes M, Griggs R. Activation of MyoD gene transcription by 3, 5, 3′-triiodothyro-L-thyronine : a direct role for the thyroid hormone and retinoid X receptors. Nucleic Acids Res 1994; 22: 583-91.
53. Rodier A. Régulation de l'expression de BTG1 dans les myoblastes aviaires. Implication dans l'effet myogénique de la T3 et de l'AMPc. Diplôme d'Etudes Approfondies, Université de Montpellier I, 1995 : 20 p.
54. Lee Y, Nadal-Ginard B, Mahdavi V. Myocyte-specific enhancer-binding factor 2 (MEF2) and thyroid hormone receptor (TR) associate and synergistically activate the α-cardiac myosin heavy chain gene. J Cell Biochem 1994; 18D (suppl): 500.
55. Cooney AJ, Tsai SY, O'Malley BW, Tsai M. Chicken ovalbumin upstream promoter transcription factor (COUP-TF) dimers bind to different GGTCA response elements, allowing COUP-TF to repress hormonal induction of the vitamin D3, thyroid hormone and retinoic acid receptors. Mol Cell Biol 1992; 12: 4153-63.
56. Cooney AJ, Leng X, Tsai SY, O' Malley BW, Tsai M. Multiple mechanisms of chicken ovalbumin upstream promoter transcription factor-dependent repression of transactivation by the vitamin D, thyroid hormone and retinoic acid receptors. J Biol Chem 1993; 268: 4152-60.
57. Muscat GEO, Rea S, Downes M. Identification of a regulatory function for an orphan receptor in muscle : COUP-TFII affects the expression of the MyoD gene family during myogenesis. Nucleic Acids Res 1995; 23: 1311-8.
58. Downes M, Carozzi AJ, Muscat GEO. Constitutive expression of the orphan receptor, Rev-erb Aα, inhibits muscle differentiation and abrogates the expression of the MyoD gene family. Mol Endocrinol 1995; 9: 1666-78.
59. Forman BM, Samuels HH. Dimerization among nuclear hormone receptors. New Biol 1990; 2: 587-94.
60. Downes M, Mynett-Johnson L, Muscat GEO. The retinoid acid and retinoid X receptors are differentially expressed during myoblast differentiation. Endocrinology 1994; 334: 2658-61.
61. Zalin RJ, Montague W. Changes in adenylate cyclase, cyclic AMP, and protein kinase levels in chick myoblasts, and their relationship to differentiation. Cell 1974; 2 : 103-8.
62. Segal G, Ingbar SH. 3, 5, 3′-triiodothyronine increases cellular adenosine 3′, 5′-monophosphate concentration and sugar uptake in rat thymocytes by stimulating adenylate cyclase activity: studies with the adenylate cyclase inhibitor MDL 12330A. Endocrinology 1989; 124: 2166-71.
63. Darbon J, Fesquet D, Cavadore J. De nouveaux regulateurs du cycle cellulaire : les protéines modulatrices des complexes Cdk-cyclines, médecine/sciences 1995; 11: 349-56.
64. Vandromme M, Carnac G, Gautier-Rouvière C, Fesquet D, Lamb N, Fernandez A. Nuclear import of the nuclear myogenic factor MyoD requires cAMP-dependent protein kinase activity but not the direct phosphorylation of MyoD. J Cell Sci 1994; 107: 613-20.
65. Goldberg Y, Glineur C, Gesquiere JC, Ricouart A, Sap J, Vennström B, Ghysdael J. Activation of protein kinase C or cAMP-dependent protein kinase increases phosphorylation of the c-erbA-encoded thyroid hormone receptor and of the v-erbA-encoded protein. EMBO J 1988; 7: 2425-33.
66. Marchal S. Influence de la triiodothyronine (T3) sur la différenciation des myoblastes aviaires. Implication de la voie AMPc. Mécanismes d'action. Thèse d'Université, Montpellier 1, 1995: 140 p.
67. Lamph WW, Dwarki VJ, Ofir R, Montminy MR, Verma IM. Negative and positive regulations by transcription factor cAMP response element-binding protein is modulated by phosphorylation. Prof Natl Acad Sci USA 1990; 87: 4320-4.
68. Hai T, Curran T. Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity. Proc Natl Acad Sci USA 1991; 88: 3720-4.
69. Ohishi S, Endo M, Kobayashi T, Terasawa T, Murakami T, Onoda M, Itoh T, Tsuiki S, Tamura S. Enhanced expression of type 2C protein phosphatase gene during myogenic differentiation of CH310T1/2 cells. Biochem Int 1992; 28: 345-51.
70. Srinivasan M, Begum N. Regulation of protein phosphatase 1 and 2A activities by insulin during myogenesis in rat skeletal muscle cells in culture. J Biol Chem 1994; 269: 12514-20.
71. Rimohk R, Rouault JP, Wahbi K, Gadoux M, Lafage M, Archimbaud E, Charrin C, Gentilhomme O, Germain D, Samarut J, Magaud JP. A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus in a t(8; 12) (q24; q22) translocation in a case of B-cell chronic lymphocytic leukemia. Genes Chrom Cancer 1991; 3: 24-36.
72. Rouault JP, Rimokh R, Tessa C, Paranhos G, Ffrench M, Duret L, Garroccio M, Germain D, Samarut J, Magaud JP. BTG1, a member of a new family of antiproliferative genes. EMBO J 1992; 11: 1663-70.
73. Segal G. Calcium is the first messenger for the action of thyroid hormone at the level of the plasma membrane : first evidence for an acute effect of thyroid hormone on calcium uptake in the heart. Endocrinology 1990; 126: 2693-702.